Clinical Trial Update: Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy and cetuximab in metastatic esophageal cancer or gastroesophageal junction cancer has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-03-15